|
1
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wood LD, Canto MI, Jaffee EM and Simeone
DM: Pancreatic cancer: Pathogenesis, screening, diagnosis, and
treatment. Gastroenterology. 163:386–402.e1. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park W, Chawla A and O'Reilly EM:
Pancreatic cancer: A review. JAMA. 326:851–862. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou
X, Wang Z, Fang Y, Pan H and Han W: Multiple primary malignant
tumors-a clinical analysis of 15,321 patients with malignancies at
a single center in China. J Cancer. 9:2795–2801. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warren S: Multiple primary malignant
tumors. A survey of the literature and a statistical study. Am J
Cancer. 16:1358–1414. 1932.
|
|
7
|
Sakellakis M, Peroukides S, Iconomou G,
Boumpoucheropoulos S and Kalofonos H: Multiple primary
malignancies: A report of two cases. Chin J Cancer Res. 26:215–218.
2014.PubMed/NCBI
|
|
8
|
Dayer N, Fasquelle F, Salati E and
Dietrich G: Multiple primary malignancies: Synchronous lymphoma,
pancreatic neuroendocrine tumour and colorectal cancer. BMJ Case
Rep. 14:e2419382021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Destri G, Giarrizzo A, Bellavia N,
Milazzotto R, Frattalone ME, Scilletta B and Di Cataldo A:
Synchronous double cancers of the colon and the pancreas: A case
report. Eur Rev Med Pharmacol Sci. 18:28–31. 2014.PubMed/NCBI
|
|
10
|
Travis LB, Demark Wahnefried W, Allan JM,
Wood ME and Ng AK: Aetiology, genetics and prevention of secondary
neoplasms in adult cancer survivors. Nat Rev Clin Oncol.
10:289–301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Travis LB, Rabkin CS, Brown LM, Allan JM,
Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele
A, et al: Cancer survivorship-genetic susceptibility and second
primary cancers: Research strategies and recommendations. J Natl
Cancer Inst. 98:15–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wood ME, Vogel V, Ng A, Foxhall L, Goodwin
P and Travis LB: Second malignant neoplasms: Assessment and
strategies for risk reduction. J Clin Oncol. 30:3734–3745. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Leone G, Pagano L, Ben-Yehuda D and Voso
MT: Therapy-related leukemia and myelodysplasia: Susceptibility and
incidence. Haematologica. 92:1389–1398. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Walsh MF, Wu G, Edmonson MN,
Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, et al:
Germline mutations in predisposition genes in pediatric cancer. N
Engl J Med. 373:2336–2346. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rahman N: Realizing the promise of cancer
predisposition genes. Nature. 505:302–308. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carbone M, Arron ST, Beutler B, Bononi A,
Cavenee W, Cleaver JE, Croce CM, D'Andrea A, Foulkes WD, Gaudino G,
et al: Tumour predisposition and cancer syndromes as models to
study gene-environment interactions. Nat Rev Cancer. 20:533–549.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sinicrope FA: Lynch syndrome-associated
colorectal cancer. N Engl J Med. 379:764–773. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Martincorena I and Campbell PJ: Somatic
mutation in cancer and normal cells. Science. 349:1483–1489. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cancer Genome Atlas Research Network.
Electronic address: andrew_aguirre@dfci.harvard.edu, . Cancer
Genome Atlas Research Network: Integrated genomic characterization
of pancreatic ductal adenocarcinoma. Cancer Cell. 32:185–203.e13.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hayashi A, Hong J and Iacobuzio-Donahue
CA: The pancreatic cancer genome revisited. Nat Rev Gastroenterol
Hepatol. 18:469–481. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
JCO Flashback: Predictive value of KRAS
mutations on the outcomes of panitumumab monotherapy in colorectal
cancer. J Clin Oncol. 41:32772023. View Article : Google Scholar
|
|
22
|
Dy GK, Govindan R, Velcheti V, Falchook
GS, Italiano A, Wolf J, Sacher AG, Takahashi T, Ramalingam SS,
Dooms C, et al: Long-term outcomes and molecular correlates of
sotorasib efficacy in patients with pretreated KRAS G12C-mutated
non-small-cell lung cancer: 2-year analysis of CodeBreaK 100. J
Clin Oncol. 41:3311–3317. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van de Haar J, Ma X, Ooft SN, van der Helm
PW, Hoes LR, Mainardi S, Pinato DJ, Sun K, Salvatore L, Tortora G,
et al: Codon-specific KRAS mutations predict survival benefit of
trifluridine/tipiracil in metastatic colorectal cancer. Nat Med.
29:605–614. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mullard A: The KRAS crowd targets its next
cancer mutations. Nat Rev Drug Discov. 22:167–171. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karlsson K, Przybilla MJ, Kotler E, Khan
A, Xu H, Karagyozova K, Sockell A, Wong WH, Liu K, Mah A, et al:
Deterministic evolution and stringent selection during
preneoplasia. Nature. 618:383–393. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Frankell AM, Dietzen M, Al Bakir M, Lim
EL, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A,
et al: The evolution of lung cancer and impact of subclonal
selection in TRACERx. Nature. 616:525–533. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen R, Fu D, Dong L, Zhang MC, Shi Q, Shi
ZY, Cheng S, Wang L, Xu PP and Zhao WL: Simplified algorithm for
genetic subtyping in diffuse large B-cell lymphoma. Signal
Transduct Target Ther. 8:1452023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iacopetta B: TP53 mutation in colorectal
cancer. Hum Mutat. 21:271–276. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fearon ER: Molecular genetics of
colorectal cancer. Ann Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aaquist T, Dembic M, Thomassen M, de
Stricker K, Bertelsen M, Christensen LG, Mortensen MB and Detlefsen
S: Synchronous detection of pancreatic adenocarcinoma and
paraganglioma in a Whipple resection specimen. Pathology Res Pract.
226:1535902021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brandler J, Wu TT and Sweetser S: Young
onset breast and colon cancer. Gastroenterology. 152:e12–e13. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirata K, Kanemitsu S, Nakayama Y, Nagata
N, Itoh H, Ohnishi H, Ishikawa H and Furukawa Y: A novel germline
mutation of MSH2 in a hereditary nonpolyposis colorectal cancer
patient with liposarcoma. Am J Gastroenterol. 101:193–196. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ottenhof NA, de Wilde RF, Morsink FH, de
Leng WW, Ausems MG, Morreau H, van Hillegersberg R, Offerhaus GJ
and Milne AN: Pancreatic ductal adenocarcinoma in hereditary
diffuse gastric cancer. A case report. Hum Pathol. 43:457–461.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Silvestris N, Zito FA, Fiore MG, Simone G,
Tommasi S, Izzi G, Guarini A and Colucci G: Synchronous
presentation of B-cell chronic lymphocytic leukemia/small-cell
lymphoma and colon adenocarcinoma within the same mesenteric lymph
nodes and a single liver metastasis. J Clin Oncol. 29:e11–e13.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hecht SS and Hatsukami DK: Smokeless
tobacco and cigarette smoking: Chemical mechanisms and cancer
prevention. Nat Rev Cancer. 22:143–155. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boffetta P and Hashibe M: Alcohol and
cancer. Lancet Oncol. 7:149–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Prabhu A, Obi KO and Rubenstein JH: The
synergistic effects of alcohol and tobacco consumption on the risk
of esophageal squamous cell carcinoma: A meta-analysis. Am J
Gastroenterol. 109:822–827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hugen N, Brown G, Glynne-Jones R, de Wilt
JH and Nagtegaal ID: Advances in the care of patients with mucinous
colorectal cancer. Nat Rev Clin Oncol. 13:361–369. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luo C, Cen S, Ding G and Wu W: Mucinous
colorectal adenocarcinoma: Clinical pathology and treatment
options. Cancer Commun (Lond). 39:132019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chu LC, Goggins MG and Fishman EK:
Diagnosis and detection of pancreatic cancer. Cancer J. 23:333–342.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mizrahi JD, Surana R, Valle JW and Shroff
RT: Pancreatic cancer. Lancet. 395:2008–2020. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Su L and Wernberg J: Synchronous distal
pancreatic metastatic lesion arising from colonic adenocarcinoma:
Case report and literature review. Clin Med Res. 12:166–170. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Conroy T, Castan F, Lopez A, Turpin A, Ben
Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, et al:
Five-year outcomes of FOLFIRINOX vs. gemcitabine as adjuvant
therapy for pancreatic cancer: A randomized clinical trial. JAMA
Oncol. 8:1571–1578. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Conroy T, Hammel P, Hebbar M, Ben
Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi
JJ, et al: FOLFIRINOX or gemcitabine as adjuvant therapy for
pancreatic cancer. N Engl J Med. 379:2395–2406. 2018. View Article : Google Scholar : PubMed/NCBI
|
